Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Ozempic in March after Novo Nordisk AS's patent for the drug expires. That would make the Indian drugmaker one of the first ...

Dr Reddy's India business saw robust double-digit growth, with revenue increasing 19% y-o-y to ₹1,603 crore. Hyderabad-based Dr Reddy’s Laboratories beat street estimates in the third quarter, ...

Hyderabad: Telangana Chief Minister A. Revanth Reddy has sought collaboration with the Harvard Kennedy School to strengthen education standards in the state during his ongoing executive leadership ...

Good day, everyone, and welcome to the Quarter 3 FY '26 Earnings Call of Dr. Reddy's Laboratories Limited. We appreciate your continued interest in our company. I'm Aishwarya Sitharam, Head of ...

Hyderabad: Chief Minister A. Revanth Reddy commenced his executive education programme at the Kennedy School of Government at Harvard University in Cambridge, Massachusetts, US. The inaugural academic ...

HYDERABAD, (IANS) – In a setback for Jhansi Reddy, a member of the Congress party, her application for Indian citizenship has been denied by Indian authorities. Jhansi Reddy, who holds American ...

FREMONT, CA — From experiencing the driverless Waymo car in San Francisco, CA, to creating a new motto for Telangana to securing a series of investment deals and partnerships aimed at propelling ...

Indian drugmaker Dr Reddy’s Laboratories Ltd is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March after the drug’s patent expiry, becoming one of the first firms to capture ...

Dr Reddy’s share price: At around 10:55 AM, the stock was trading at Rs 1,217.20, up Rs 60.00 or 5.18 per cent. The share opened at Rs 1,195, touched a high of Rs 1,224.50 and a low of Rs 1,187.70.

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active ...